drugset / Trial / NCT00208702

Thyroid Medication and Antidepressants for Treating Major Depression

NCT00208702

RandomizedSingle-groupDouble-blindTreatment

Summary

This study will evaluate the effectiveness of treatment with supplemental triiodothyronine (T3, Cytomel) and sertraline (Zoloft), a selective serotonin reuptake inhibitor (SSRI), in improving symptoms of major depressive disorder (MDD).

Timeline

Start
1996-09
Primary completion
2003-07
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Liothyronine Small molecule 50 ug
Subject Sertraline Small molecule